Julia Sauer

Dr. Julia Sauer

Modern Microbial Technologies, Boehringer Ingelheim, Biberach an der Riss, Germany
orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 December 2022 in Journal of Cell Biology
Verified
Journal Article
Open access
PDF file
DSDaniela Schloesser
Daniela Schloesser
LLLaura Lindenthal
Laura Lindenthal
Julia SauerJulia Sauer
Julia Sauer
KCKyoung-Jin Chung
Kyoung-Jin Chung
TCTriantafyllos Chavakis
Triantafyllos Chavakis
PMPeter J. Murray
Peter J. Murray
Progressive accrual of senescent cells in aging and chronic diseases is associated with detrimental effects in tissue homeostasis. We found that senescent fibroblasts and epithelia were not only refractory to macrophage-mediated engulfment and removal, but they also paralyzed the ability of macrophages to remove bystander apoptotic corpses. Senescent cell-mediated efferocytosis suppression (SCES) was independent of the senescence-associated secretory phenotype (SASP) but instead required direct contact between macrophages and senescent cells. SCES involved augmented senescent cell expression of CD47 coinciding with increased CD47-modifying enzymes QPCT/L. SCES was reversible by interfering with the SIRPα-CD47-SHP-1 axis or QPCT/L activity. While CD47 expression increased in human and mouse senescent cells in vitro and in vivo, another ITIM-containing protein, CD24, contributed to SCES specifically in human epithelial senescent cells where it compensated for genetic deficiency in CD47. Thus, CD47 and CD24 link the pathogenic effects of senescent cells to homeostatic macrophage functions, such as efferocytosis, which we hypothesize must occur efficiently to maintain tissue homeostasis.

3 April 2024 in Frontiers in Immunology
Verified
Journal Article
Open access
PDF file
Julia SauerJulia Sauer
Julia Sauer
ASAgnes A. Steixner-Kumar
Agnes A. Steixner-Kumar
SGSvenja Gabler
Svenja Gabler
MMMaciej Motyka
Maciej Motyka
JRJörg F. Rippmann
Jörg F. Rippmann
EBEhsan Bahrami
Ehsan Bahrami
Chronic liver diseases, such as non-alcoholic steatohepatitis (NASH)-induced cirrhosis, are characterized by an increasing accumulation of stressed, damaged, or dying hepatocytes. Hepatocyte damage triggers the activation of resident immune cells, such as Kupffer cells (KC), as well as the recruitment of immune cells from the circulation toward areas of inflammation. After infiltration, monocytes differentiate into monocyte-derived macrophages (MoMF) which are functionally distinct from resident KC. We herein aim to compare the in vitro signatures of polarized macrophages and activated hepatic stellate cells (HSC) with ex vivo-derived disease signatures from human NASH. Furthermore, to shed more light on HSC activation and liver fibrosis progression, we investigate the effects of the secretome from primary human monocytes, macrophages, and NK cells on HSC activation. Interleukin (IL)-4 and IL-13 treatment induced transforming growth factor beta 1 (TGF-β1) secretion by macrophages. However, the supernatant transfer did not induce HSC activation. Interestingly, PMA-activated macrophages showed strong induction of the fibrosis response genes COL10A1 and CTGF, while the supernatant of IL-4/IL-13-treated monocytes induced the upregulation of COL3A1 in HSC. The supernatant of PMA-activated NK cells had the strongest effect on COL10A1 induction in HSC, while IL-15-stimulated NK cells reduced the expression of COL1A1 and CTGF. These data indicate that other factors, aside from the well-known cytokines and chemokines, might potentially be stronger contributors to the activation of HSCs and induction of a fibrotic response, indicating a more diverse and complex role of monocytes, macrophages, and NK cells in liver fibrosis progression.

16 April 2023 in SLAS Discovery
Verified
Journal Article
Open access
SGSarah Groetzner
Sarah Groetzner
MHMozhgan Dehghan Harati
Mozhgan Dehghan Harati
KKKarim C. El Kasmi
Karim C. El Kasmi
DSDaniela Schloesser
Daniela Schloesser
Julia SauerJulia Sauer
Julia Sauer
RHRalf Heilker
Ralf Heilker
Macrophages play a pivotal role in drug discovery due to their key regulatory functions in health and disease. Overcoming the limited availability and donor variability of human monocyte-derived macrophages (MDMs), human induced pluripotent stem cell (iPSC)-derived macrophages (IDMs) could provide a promising tool for both disease modeling and drug discovery. To access large numbers of model cells for medium- to high-throughput application purposes, an upscaled protocol was established for differentiation of iPSCs into progenitor cells and subsequent maturation into functional macrophages. These IDM cells resembled MDMs both with respect to surface marker expression and phago- as well as efferocytotic function. A statistically robust high-content-imaging assay was developed to quantify the efferocytosis rate of IDMs and MDMs allowing for measurements both in the 384- and 1536-well microplate format. Validating the applicability of the assay, inhibitors of spleen tyrosine kinase (Syk) were shown to modulate efferocytosis in IDMs and MDMs with comparable pharmacology. The miniaturized cellular assay with the upscaled provision of macrophages opens new routes to pharmaceutical drug discovery in the context of efferocytosis-modulating substances.

7 August 2025 in The Journal of Immunology
Verified
Journal Article
Closed access
Julia SauerJulia Sauer
Julia Sauer
DSDaniela Schloesser
Daniela Schloesser
KKKatja Koeppen
Katja Koeppen
KFKatrin Fundel-Clemens
Katrin Fundel-Clemens
CSChantelle Simone-Roach
Chantelle Simone-Roach
KKKarim Christian El Kasmi
Karim Christian El Kasmi
Human macrophages differ from their mouse counterparts in multiple metabolic pathways, surface protein expression, and transcription factor biology. Monocyte-derived macrophages (MDMs) from blood are generally used to study human macrophage biology in vitro. However, the use of MDMs as a human macrophage model is limited by donor-to-donor variability, total cell availability, preactivation effects, and relative resistance to genetic manipulation. Here, we explored stem cell–derived macrophages to study in vitro disease-relevant macrophage phenotypes. We compared induced pluripotent stem cell–derived macrophages (iDMs) with primary human stem cell–derived macrophages from cord blood–derived macrophages or bone marrow–derived macrophages (BMDMs) in their ability to elaborate tissue and disease-relevant phenotypes in comparison with conventional blood MDMs. Analyses of phenotypical and functional features revealed that iDMs were highly similar to cord blood–derived macrophages and BMDMs, and resembled MDMs. Importantly, all macrophages, and particularly iDMs adopted expected disease-relevant phenotypes in vitro when stimulated with disease-associated mediators. RNA sequencing analyses of in vitro macrophages stimulated with tissue relevant factors revealed that their transcriptomes mapped to human in vivo inflammatory conditions. Using this approach, we found a close correlation between stimulation and expected disease-association counterpart in vivo. In conclusion, we established a streamlined system to link stem cell–derived macrophage phenotypes to relevant macrophage phenotypes in disease states. Thus, enabling conditions for in vitro replication of complex human macrophage biology observed in single-cell RNA sequencing from human diseased tissue.

Verified
Journal Article
Open access
PDF file
JBJohanna Brüggenthies
Johanna Brüggenthies
JDJakob Dittmer
Jakob Dittmer
EMEva Martin
Eva Martin
IZIgor Zingman
Igor Zingman
ITIbrahim Tabet
Ibrahim Tabet
BWBernd Weigle
Bernd Weigle
Macrophage polarization critically contributes to a multitude of human pathologies. Hence, modulating macrophage polarization is a promising approach with enormous therapeutic potential. Macrophages are characterized by a remarkable functional and phenotypic plasticity, with pro-inflammatory (M1) and anti-inflammatory (M2) states at the extremes of a multidimensional polarization spectrum. Cell morphology is a major indicator for macrophage activation, describing M1(-like) (rounded) and M2(-like) (elongated) states by different cell shapes. Here, we introduced cell painting of macrophages to better reflect their multifaceted plasticity and associated phenotypes beyond the rigid dichotomous M1/M2 classification. Using high-content imaging, we established deep learning- and feature-based cell painting image analysis tools to elucidate cellular fingerprints that inform about subtle phenotypes of human blood monocyte-derived and iPSC-derived macrophages that are characterized as screening surrogate. Moreover, we show that cell painting feature profiling is suitable for identifying inter-donor variance to describe the relevance of the morphology feature ‘cell roundness’ and dissect distinct macrophage polarization signatures after stimulation with known biological or small-molecule modulators of macrophage (re-)polarization. Our novel established AI-fueled cell painting analysis tools provide a resource for high-content-based drug screening and candidate profiling, which set the stage for identifying novel modulators for macrophage (re-)polarization in health and disease.

7 June 2026 in The Journal of Immunology
Verified
Journal Article
Open access
Julia SauerJulia Sauer
Julia Sauer
POPatricia P Ogger
Patricia P Ogger
JDJasmina Dukic
Jasmina Dukic
ANAlina Nessensohn
Alina Nessensohn
SGSvenja Gabler
Svenja Gabler
PMPeter J Murray
Peter J Murray
In inflammatory tissue niches, macrophages encounter intense oxidative stress due to their own production of reactive oxygen and nitrogen species as part of antimicrobial defense. Our findings reveal that inflammatory macrophages deploy distinct, context-dependent redox-protective mechanisms to survive this self-inflicted stress, thereby avoiding ferroptotic cell death. Specifically, LPS-activated macrophages, M(LPS), rely on the GTP cyclohydrolase 1 (GCH1)–tetrahydrobiopterin (BH4) pathway for ferroptosis resistance, whereas LPS + IFN-γ–activated macrophages, M(LPS–IFN-γ), depend primarily on nitric oxide produced by inducible nitric oxide synthase (iNOS)—with the BH4 pathway suppressing cell death in the absence of nitric oxide. These distinct adaptations highlight a novel GCH1–BH4–iNOS axis that governs macrophage ferroptosis susceptibility. In both the LPS or the LPS + IFN-γ–activated settings, the redox-protective phenotype is reversible: Removal of inflammatory stimuli abolishes the protection, indicating that this metabolic programming requires continuous stimulation and is not a permanently fixed state. These findings uncover redox metabolism-guided metabolic distinctions between inflammatory macrophages and reveal how they preserve viability over prolonged inflammatory activation. Ultimately, our findings establish the GCH1–BH4–iNOS axis as a central, targetable mechanism to manipulate macrophage ferroptosis resistance for therapeutic purposes.